O43353 (RIPK2_HUMAN) Homo sapiens (Human)

Receptor-interacting serine/threonine-protein kinase 2 UniProtKBInterProSTRINGInteractive Modelling

540 aa; Sequence (Fasta) ; (Isoform 2); 1 identical sequence: Homo sapiens: A0A0S2Z4Z8

Available Structures

31 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of RIP2K dimer bound to the XIAP BIR2 domain Heteromer
P98170;
8-314
ZN;
Assess
p75NTR DD:RIP2 CARD Heteromer
P08138;
435-539
Assess
Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide Heteromer
P31947;
535-540
CA;MG;
Assess
Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide and stabilizer Fusicoccin-A Heteromer
P31947;
536-540
FSC;MG;CL;
Assess
Structure of RIP2 CARD domainhomo-12-mer434-516
Assess
Structure of RIP2 CARD filamenthomo-10-mer433-518
Assess
Structure of RIP2 CARD domain fused to crystallisable MBP taghomo-4-mer435-522
GLC;
Assess
Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3homo-2-mer5-316
KRE;
Assess
Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18homo-2-mer5-316
E7N;
Assess
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-in…homo-2-mer2-310
6GE;SO4;
Assess
Structure of the kinase domain of human RIPK2 in complex with ponatinibhomo-2-mer8-316
0LI;EDO;
Assess
RIP2 Kinase Catalytic Domain (1 - 310)homo-2-mer4-310
CA;
Assess
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-in…homo-2-mer4-310
6GD;
Assess
RIP2 Kinase Catalytic Domain complex with 2({4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)…homo-2-mer4-310
KA2;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with Benzimidazolehomo-2-mer4-310
CA;IQ7;
Assess
RIP2 Kinase Catalytic Domain complex with N(4,5dimethyl1Hpyrazol3yl)7methoxy6(2methylpropane2sulfon…homo-2-mer5-310
GEZ;
Assess
RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide.homo-2-mer5-310
M5W;CA;
Assess
RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)q…homo-2-mer5-310
K9T;CA;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with SB-203580homo-2-mer5-310
SB2;
Assess
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.homo-2-mer5-310
9XA;
Assess
RIP2 Kinase Catalytic Domain complex with 5-Amino-1-Phenylpyrazole-4-Carboxamide.homo-2-mer5-310
M2B;CA;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with Biaryl Ureahomo-2-mer6-310
SR8;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with AMP-PCPhomo-2-mer6-310
ACP;MG;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with Biphenylsulfonamidehomo-2-mer8-310
XYW;
Assess
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseaseshomo-2-mer9-311
9WS;SO4;
Assess
Structure of RIP2K(L294F) with bound AMPPCPhomo-2-mer5-300
ACP;MG;CO;
Assess
Structure of RIP2K(D146N) with bound Staurosporinehomo-2-mer5-298
STU;PO4;
Assess
Crystal structure of the kinase domain of human RIPK2 in complex with the activation loop targeting…monomer5-316
BW8;
Assess
RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9…monomer5-310
Q9J;
Assess
Structure of inactive kinase RIP2K(K47R)monomer9-297
SO4;
Assess
Solution structure of RIP2 CARDmonomer434-539
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6s1f.1.Ahomo-2-mer0.785-316
KRE;100.00
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26es0.2.Amonomer0.671-178
100.00
Assess
Isoform 26ggs.1.Amonomer0.66296-381
100.00
Assess